ClinicalTrials.govpublic full text
Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
acute myeloid leukemia, acute myeloid leukemia post cytotoxic therapy, acute myeloid leukemia with multilineage dysplasia, chronic myelomonocytic leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 879643
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.